Jennifer Buell - 09 Sep 2025 Form 4/A - Amendment Insider Report for MiNK Therapeutics, Inc. (INKT)

Role: Chief Executive Officer
Signature: By: /s/ Christine Klaskin, Attorney-in-Fact
Issuer symbol: INKT
Transactions as of: 09 Sep 2025
Net transactions value: -$82,191
Form type: 4/A - Amendment
Filing time: 03 Oct 2025, 16:05:24 UTC
Date Of Original Report: 11 Sep 2025
Previous filing: 06 May 2025
Next filing: 14 Jan 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Buell Jennifer	Chief Executive Officer	149 FIFTH AVENUE, SUITE 500, NEW YORK	By: /s/ Christine Klaskin, Attorney-in-Fact	03 Oct 2025	0001711184

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	INKT	Common Stock	Tax liability	$82,191	-5,351	-13%	$15.36	36,492	09 Sep 2025	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares were withheld for payment of the withholding taxes in relation to the stock issued to reporting person on September 9, 2025, as previously reported on the Form 4 filed on September 11, 2025 (the "Original Form 4"). The Original Form 4 did not include the shares withheld for payment of withholding taxes in Table I. This amendment is being filed to correct this error.